ACTIVATING POINT MUTATION OF BRCA1/2 GENES IN AZERBAIJAN POPULATION
- 作者: Aliyev J.A1, Melikova L.A1, Mansurov E.B1, Aliyeva F.K1, Bagirova E.E1, Mexdizade S.Q1, Nadjafova A.S1
-
隶属关系:
- National Center of Oncology
- 期: 卷 17, 编号 2 (2019)
- 页面: 39-43
- 栏目: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113063
- DOI: https://doi.org/10.29296/24999490-2019-02-05
- ID: 113063
如何引用文章
详细
全文:
作者简介
J. Aliyev
National Center of OncologyBaku, Azerbaijan
L. Melikova
National Center of Oncology
Email: Lmelikova20027@gmail.com
Baku, Azerbaijan
E. Mansurov
National Center of OncologyBaku, Azerbaijan
F. Aliyeva
National Center of OncologyBaku, Azerbaijan
E. Bagirova
National Center of OncologyBaku, Azerbaijan
S. Mexdizade
National Center of OncologyBaku, Azerbaijan
A. Nadjafova
National Center of OncologyBaku, Azerbaijan
参考
- Алиев Д.А., Марданлы Ф.А., Ватанха С.С., Мансуров Э.Б. Эпидемиологические аспекты заболеваемости раком молочной железы в Азербайджанской Республике за период 2012-2016 гг. Azerbaijan J. of Oncology. 2017; 1: 76-8. (Aliyev J.A., Mardanli FA., Vatankha S.S., Mansurov E.B. Epidemiological aspects of the incidence of breast cancer in the Republic of Azerbaijan for the period 2012-2016. Azerbaijan Oncology J. 2017; 1: 76-8 (in Russian)]
- Statistical yearbook of Azerbaijan. State statistical committee of the republic of Azerbaijan. 2017; 824.
- Lynch H.T., Snyder C., Lynch J. Hereditary breast cancer: practical pursuit for clinical translation. Annals of Surgical Oncology. 2012; 19 (6): 1723-31.
- Deng C.X., Wang R.H. Roles of BRCA1 in DNA damage repair: a link between development and cancer. Human Molecular Genetics. 2003; 12 (1): 113-23.
- NHGRI: Breast Cancer Information Core. https://research.nhgri.nih.gov/bic/
- Любченко Л.Н., Батенева Е.И., Воротников И.К. Портной С.М., Крохина О.В., Соболевский В.А., Жукова Л.Г., Хайленко В.А., Тюляндин С.А. Наследственный рак молочной железы: генетическая и клиническая гетерогенность, молекулярная диагностика, хирургическая профилактика в группах риска. Успехи молекулярной онкологии. 2014; 2: 16-25.
- Дмитриев И.В., Сухотерин И.И., Зыбенко Т.В., Дмитриева Т.В. Мутации генов BRCA 1, BRCA 2 - будущее предикативной онкологии: обзор литературы. Маммология. 2012; 1: 13-6. (Dmitriev I.V., Sukhoterin I.I., Zibenko T.V., Dmitrieva T.V. Mutation of the genes BRCA1, BRCA2 - the future of predictive Oncology: a review of the literature. Mammalogy. 2012; 1: 13-6 (in Russian)]
- Hyuna Sung, Philip S. Rosenberg, Wan-Qing Chen et al. Female Breast Cancer Incidence among Asian and Western Populations: More Similar Than Expected. J. of the National Cancer Institute. 2015; 107 (7): 107.
- Fatemeh K., Parvin M. A comprehensive Focus on Global Spectrum of BRCA1 and BRCA2 mutations in breast cancer. BioMed Research International. 2013; 928562: 21. http://dx.doi.org/10.1155/2013/928562
- Pohlreich P., Michal Z., Jana S.High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area. Breast cancer research. 2005; 7 (5): 728-36.
- Antoniou A.C., Pharoah P.D., Narod S., Risch H.C., et al. Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. Letter to JMG. 2010; 42 (7): 5-7.
- Balci A., Huusko P., Paakkonen K. et al. Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families: a novel mutation BRCA2 3414del4 found in male breast cancer. European J. of Cancer. 1999; 35 (5): 707-10.